4//SEC Filing
Isett Thomas Francis 3rd 4
Accession 0001638599-20-000306
CIK 0001420720other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 7:45 PM ET
Size
13.7 KB
Accession
0001638599-20-000306
Insider Transaction Report
Form 4
iBio, Inc.IBIO
Isett Thomas Francis 3rd
Director
Transactions
- Award
Stock Option (right to buy)
2020-03-12$1.43/sh+975,000$1,394,250→ 1,275,000 totalExercise: $1.43Exp: 2025-03-11→ Common Stock (975,000 underlying) - Other
Series B Warrants (Right to Buy)
2020-02-20$1000.00/sh−21,976$21,976,000→ 1,275,000 totalExercise: $0.22From: 2019-10-29Exp: 2026-10-29→ Common Stock (21,976 underlying) - Other
Common Stock
2020-02-20+121,976→ 1,275,000 total - Other
Series A Warrants (Right to Buy)
2020-02-20$1000.00/sh−100,000$100,000,000→ 1,275,000 totalExercise: $0.22From: 2019-10-29Exp: 2021-10-29→ Common Stock (100,000 underlying)
Footnotes (6)
- [F1]Issued pursuant to an Exchange Agreement with iBio, Inc. ("iBio") pursuant to which Mr. Isett exchanged Series A Warrants to purchase 100,000 shares of iBio's common stock ("Common Stock") and Series B Warrants to purchase 21,976 shares of Common Stock in exchange for 121,976 shares of Common Stock and a promissory note in the principal amount of $26,834. In addition, Series B Warrants to purchase 78,024 shares of Common Stock held by Mr. Isett were amended in connection with the Exchange Agreement.
- [F2]Reflects number of securities beneficially owned following all transactions reported on this Form 4, on an as converted to common stock basis.
- [F3]The Warrants were acquired by Mr. Isett in a public offering by iBio on October 29, 2019.
- [F4]Exchanged pursuant to an Exchange Agreement with iBio pursuant to which Mr. Isett exchanged Series A Warrants to purchase 100,000 shares of Common Stock and Series B Warrants to purchase 21,976 shares of Common Stock in exchange for 121,976 shares of Common Stock and a promissory note in the principal amount of $26,834.
- [F5]The Warrants were sold together with Series C Preferred Shares in a public offering on October 29, 2019. Each of Series C Preferred Share was sold together with Series A Warrants to purchase one share of common stock for each share of common stock issuable upon conversion of the Series C Preferred Share and Series B Warrants to purchase one share of common stock for each share of common stock issuable upon conversion of the Series C Preferred Share. Each Series C Preferred Share and accompanying Series A Warrants and Series B Warrants was sold at a combined public offering price of $1,000.
- [F6]Vests ratably over a 36-month period beginning on date of grant (1/36th per month) and will be deemed fully-vested upon any transaction or series of related transactions that constitutes a Change of Control Transaction (as defined in the grant agreement).
Documents
Issuer
iBio, Inc.
CIK 0001420720
Entity typeother
Related Parties
1- filerCIK 0001773100
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 7:45 PM ET
- Size
- 13.7 KB